Cristal Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Cristal Therapeutics's estimated annual revenue is currently $1.4M per year.
- Cristal Therapeutics's estimated revenue per employee is $201,000
Employee Data
- Cristal Therapeutics has 7 Employees.
- Cristal Therapeutics grew their employee count by 0% last year.
Cristal Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder and CSO | Reveal Email/Phone |
Cristal Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Cristal Therapeutics?
Cristal Therapeutics is a pharmaceutical company developing superior products based on its proprietary CriPec® platform. Cristal Therapeutics' mission is to improve the therapeutic performance of drugs resulting in commercial opportunities in various disease areas. The application of CriPec® potentially results in a better efficacy and enhanced tolerability due to an improved disposition. The first product that is independently being developed by Cristal Therapeutics is CriPec® docetaxel for the treatment of solid tumours. The company is founded in April 2011 and based in Maastricht, The Netherlands
keywords:N/AN/A
Total Funding
7
Number of Employees
$1.4M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.9M | 15 | 7% | N/A |
#2 | $3.1M | 19 | 0% | N/A |
#3 | $5.1M | 40 | 48% | N/A |
#4 | $5.3M | 40 | 5% | N/A |
#5 | $7.5M | 42 | 45% | N/A |